Cargando…
QbD Based Media Development for the Production of Fab Fragments in E. coli
Ranibizumab is a biotherapeutic Fab fragment used for the treatment of age-related macular degeneration and macular oedema. It is currently expressed in the gram-negative bacterium, Escherichia coli. However, low expression levels result in a high manufacturing cost. The protein expression can be in...
Autores principales: | Kumar, Deepak, Batra, Jyoti, Komives, Claire, Rathore, Anurag S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631317/ https://www.ncbi.nlm.nih.gov/pubmed/30925730 http://dx.doi.org/10.3390/bioengineering6020029 |
Ejemplares similares
-
Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques
por: Peltonen, Leena
Publicado: (2018) -
Hybrid modeling as a QbD/PAT tool in process development: an industrial E. coli case study
por: von Stosch, Moritz, et al.
Publicado: (2016) -
Implementation of QbD strategies in the inoculum expansion of a mAb production process
por: Böhl, Ole Jacob, et al.
Publicado: (2020) -
Early Implementation of QbD in Biopharmaceutical Development: A Practical Example
por: Zurdo, Jesús, et al.
Publicado: (2015) -
Pharmaceutical Development and Design of Thermosensitive Liposomes Based on the QbD Approach
por: Dobó, Dorina Gabriella, et al.
Publicado: (2022)